Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 3
Submit an article Journal homepage
1,390
Views
12
CrossRef citations to date
0
Altmetric
Psychiatry

A review of aripiprazole long-acting injection

Pierre ChueUniversity of Alberta, Edmonton, Alberta, CanadaCorrespondence[email protected]
&
James ChueClinical Trials and Research Program, Edmonton, Alberta, Canada
Pages 441-452 | Accepted 16 Nov 2015, Published online: 29 Dec 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Orkun Aydın & Pınar Ünal-Aydın. (2017) Long-acting injectable aripipirazole-induced akathisia. Psychiatry and Clinical Psychopharmacology 27:4, pages 429-430.
Read now

Articles from other publishers (11)

Anil B. Jindal, Atharva R. Bhide, Sagar Salave, Dhwani Rana & Derajram Benival. (2023) Long-acting parenteral drug delivery systems for the treatment of chronic diseases. Advanced Drug Delivery Reviews 198, pages 114862.
Crossref
Juan J. Fernández-Miranda, Silvia Díaz-Fernández & Francisco López-Muñoz. (2021) Adherence, Tolerability and Effective Doses of Aripiprazole Once-monthly in the Long-term Treatment of Patients with Severe Schizophrenia. Current Pharmaceutical Design 27:39, pages 4078-4085.
Crossref
Adam J.S. McCartan, David W. Curran & Randall J. Mrsny. (2021) Evaluating parameters affecting drug fate at the intramuscular injection site. Journal of Controlled Release 336, pages 322-335.
Crossref
Nora Palomar-Ciria, Marta Migoya-Borja, Fanny Cegla-Schvartzman, Santiago Ovejero, Raquel Alvarez-Garcia, Hugo J. Bello & Enrique Baca-García. (2021) Early administration of aripiprazole long-acting injectable in acute inpatients with schizophrenia: a clinical report. International Clinical Psychopharmacology 36:2, pages 97-100.
Crossref
Michael M. C. Wong, Albert K. K. Chung, Timothy M. H. Yeung, David T. W. Wong, C. K. Lee, Eric Lai, Gloria F. Y. Chan, Gregory K. L. Mak, Jessica O. Y. Wong, Roger M. K. Ng, K. L. Tam & K. Y. Mak. (2020) Consensus statements on the clinical usage and characteristics of aripiprazole for Hong Kong. Internal Medicine Journal 50:S3, pages 6-14.
Crossref
Arvind Kumar, Harpreet Singh, Amrita Mishra & Arun K. Mishra. (2020) Aripiprazole: An FDA Approved Bioactive Compound to Treat Schizophrenia- A Mini Review. Current Drug Discovery Technologies 17:1, pages 23-29.
Crossref
Sally Mustafa, Joanna Bougie, Maia Miguelez, Guerline Clerzius, Emmanouil Rampakakis, Jean Proulx & Ashok Malla. (2019) Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study. BMC Psychiatry 19:1.
Crossref
Paolo Girardi, Antonio Del Casale, Chiara Rapinesi, Georgios D. Kotzalidis, Francesca Splendori, Claudio Verzura, Giada Trovini, Serena Sorice, Dario Carrus, Iginia Mancinelli, Anna Comparelli, Sergio De Filippis, Antonio Francomano, Andrea Ballerini, Andrea Marcellusi, Francesco S. Mennini, Giuseppe Ducci, Gabriele Sani, Maurizio Pompili & Roberto Brugnoli. (2018) Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate. Human Psychopharmacology: Clinical and Experimental 33:3, pages e2658.
Crossref
Xinyi Tan, Yue Zhong, Luying He, Yuanyuan Zhang, Guanghui Jing, Song Li, Jing Wang, Haibing He & Xing Tang. (2016) Morphological and Crystalline Transitions in Monohydrous and Anhydrous Aripiprazole for a Long-Acting Injectable Suspension. AAPS PharmSciTech 18:4, pages 1270-1276.
Crossref
Gianna SepedeGiuseppe Di IorioMaria Chiara SpanoMarco LorussoFabiola SarchioneRita SantacroceRosa Maria SalernoMassimo Di Giannantonio. (2016) A Case of Resistant Schizophrenia Successfully Treated With Clozapine/Long-acting Injectable Aripiprazole Combination. Clinical Neuropharmacology 39:6, pages 322-324.
Crossref
Yuko Yasuhara, Tetsuya Tanioka, Kensaku Takase, Kazushi Motoki, Chie Watari, Koichi Makiguchi, Asumi Atsuta & Rozzano C. Locsin. (2016) Intramuscular Diffusion Status of Risperidone and Aripiprazole Long Acting Injectable (LAI) by Ultrasonography. Open Journal of Psychiatry 06:02, pages 165-172.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.